Research & Evidence

At Meadow Health, our approach is informed by peer-reviewed research and real-world clinical experience.

Our care model is built on decades of peer-reviewed studies investigating the biological contributors to autism and related neurodevelopmental conditions, and how targeted, research-informed approaches may help support children's development, health, and quality of life.

This content is for informational, educational, and entertainment purposes only; it is not medical advice, diagnosis, or treatment. This content may include discussion of off-label, non-FDA-approved uses of Leucovorin (folinic acid). Cited clinical data does not guarantee results. Meadow Biosciences provides telehealth access to licensed providers, who make independent decisions. Consult a healthcare professional before making healthcare changes; seek emergency care if needed. Compounded medications are not reviewed or approved by the U.S. Food and Drug Administration (FDA) for safety, efficacy, or quality. These products are prepared to meet the unique needs of an individual patient based on a valid prescription from a licensed prescriber.
Landmark Clinical Trial

Folinic Acid (Leucovorin) in Autism

One of the most influential studies in this field is the 2016 randomized, double-blind, placebo-controlled clinical trial published in Molecular Psychiatry:

"Folinic acid improves verbal communication in children with autism and language impairment."

Published in Molecular Psychiatry, 2016

Why This Study Is Important?

  • It was a gold-standard clinical trial (randomized, double-blind, placebo-controlled)
  • It focused on verbal communication, a core challenge for many children with autism
  • It identified a biological subgroup—children with folate receptor alpha autoantibodies (FRAA)—who showed the greatest response
  • The trial reported statistically significant improvements in verbal communication scores in the treatment group, particularly among FRAA-positive children

Replicated, not isolated science

This growing body of evidence suggests that leucovorin, when used in appropriate clinical contexts, may benefit certain children, particularly those with identified folate transport abnormalities.

Replicated in multiple independent studies View study

Supported by growing research on folate transport, autoantibodies, and brain metabolism View study

Integrated into broader systems-biology models of autism View study

Meadow Health's direct connection

Meadow Health's leadership team includes a co-investigator on this landmark trial.

Our team didn't just read about this research. We helped generate it, analyze it, and translate it into clinical practice.

That experience informs:

How we evaluate children

Our evaluation protocols are informed by published clinical trial methodology and biomarker research.

How we prescribe and dose leucovorin

Dosing protocols are informed by published peer-reviewed research, including studies our leadership team co-authored.

How we monitor safety and response

Safety monitoring is informed by the protocols used in published clinical trials.

How we educate families and clinicians

We translate peer-reviewed findings into clear, accessible guidance for families and care teams.

The Meadow Difference

Meadow Health was built to close that gap by connecting high-quality research with personalized, accessible care, delivered by licensed clinicians through a national telehealth model.

Many families struggle to access care that is:

Research-Informed

Our protocols reference peer-reviewed studies and published clinical findings.

Biologically Informed

We use biomarker testing to guide clinical decisions, not one-size-fits-all approaches.

Clinically Supervised

Licensed clinicians oversee every patient journey, from intake through ongoing care.

Free from Fillers

Free from unnecessary fillers, dyes, and shortcuts.

Meadow Health's Commitment

Advancing Autism Care Through Research

Working to connect published research with personalized, accessible care. Our licensed clinicians deliver care through our national telehealth program.

We remain committed to:

  • Scientific integrity
  • Transparency with families
  • Ongoing research and learning
  • Putting children’s health and wellbeing first

Want to Learn More?

For families interested in the science behind Meadow Health, or how research informs your child's care, our team is always happy to help.

Start Your Child's Evaluation

Ready to explore leucovorin for your child?

Our leadership team didn't just read about this research. They helped create it. If you've been looking for a dedicated, clinician-led leucovorin program, this is it. No pressure, no hype. Just careful evaluation and honest answers.

Start Your Child's Evaluation